Biosurfactant based therapy against Covid19 from hand sanitization to ARDS treatment: A proposed research hypothesis

Huria Rizvi, M. Ashish
{"title":"Biosurfactant based therapy against Covid19 from hand sanitization to ARDS treatment: A proposed research hypothesis","authors":"Huria Rizvi, M. Ashish","doi":"10.55031/mshare.2021.40.cd.8","DOIUrl":null,"url":null,"abstract":"The coronavirus disease 2019 (COVID-19) worldwide pandemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus transmission occurs from person to person through air in the form of droplets through cough or sneezes. SARS-CoV-2 can survive on different surfaces and time of survival depends on a many of factors like surface type, temperature, relative humidity and type of viral strain. Presently, there is neither a cure nor a vaccine for COVID-19 and that’s what makes the spread of disease so terrifying. Surfactant based sanitization become a primitive measure to stop the spreading of COVID-19. We propose that biosurfactant based therapy and its action against COVID-19 through use of a biosurfactant-based handwashes, gargle or mouthwash, nasal and eye drops can act against SARS-CoV-2 by damaging viral spike glycoproteins (peplomers) due to its amphiphilic nature and micelle formation by biosurfactant corona virus gets entrapped inside the micelle and so washed out from the surface. This hypothesis reveals the role of biosurfactant against corona virus and Acute Respiratory Distress Syndrome (ARDS) caused by SARS-CoV-2. Biosurfactant can be administered in the form of aerosol to the patients through oral route which will directly reach into infected part of lungs, thereby, dissolving the enveloped virus capsid and also increase in the alveolar surface area. Amphiphilic nature biosurfactant entraps and block the hydrophobic spike protein of corona virus molecule by forming micelle around the spike protein which results in S1 & S2 subunits not allowed to attach to lungs membrane and breaking the corona virus membrane, hence, dissociation of spike protein from membrane will occur. The biosurfactant administered into the lungs against COVID-19 will also reduce the surface tension and thus the collapsing pressure. Thereby, result an increase in the alveolar surface area which enables normal functioning of lungs. This research on relevant animal model, carefully designed and characterized to be a crucial step for testing hypothesis at the organism level, will prove to be essential for the validation of human data.","PeriodicalId":233824,"journal":{"name":"MINDSHARE: International Journal of Research and Development","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MINDSHARE: International Journal of Research and Development","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55031/mshare.2021.40.cd.8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The coronavirus disease 2019 (COVID-19) worldwide pandemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus transmission occurs from person to person through air in the form of droplets through cough or sneezes. SARS-CoV-2 can survive on different surfaces and time of survival depends on a many of factors like surface type, temperature, relative humidity and type of viral strain. Presently, there is neither a cure nor a vaccine for COVID-19 and that’s what makes the spread of disease so terrifying. Surfactant based sanitization become a primitive measure to stop the spreading of COVID-19. We propose that biosurfactant based therapy and its action against COVID-19 through use of a biosurfactant-based handwashes, gargle or mouthwash, nasal and eye drops can act against SARS-CoV-2 by damaging viral spike glycoproteins (peplomers) due to its amphiphilic nature and micelle formation by biosurfactant corona virus gets entrapped inside the micelle and so washed out from the surface. This hypothesis reveals the role of biosurfactant against corona virus and Acute Respiratory Distress Syndrome (ARDS) caused by SARS-CoV-2. Biosurfactant can be administered in the form of aerosol to the patients through oral route which will directly reach into infected part of lungs, thereby, dissolving the enveloped virus capsid and also increase in the alveolar surface area. Amphiphilic nature biosurfactant entraps and block the hydrophobic spike protein of corona virus molecule by forming micelle around the spike protein which results in S1 & S2 subunits not allowed to attach to lungs membrane and breaking the corona virus membrane, hence, dissociation of spike protein from membrane will occur. The biosurfactant administered into the lungs against COVID-19 will also reduce the surface tension and thus the collapsing pressure. Thereby, result an increase in the alveolar surface area which enables normal functioning of lungs. This research on relevant animal model, carefully designed and characterized to be a crucial step for testing hypothesis at the organism level, will prove to be essential for the validation of human data.
基于生物表面活性剂的抗covid - 19治疗从手部卫生到ARDS治疗:一个拟议的研究假设
2019冠状病毒病(COVID-19)是由严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)引起的全球大流行疾病。这种病毒通过咳嗽或打喷嚏时以飞沫的形式通过空气在人与人之间传播。SARS-CoV-2可以在不同的表面上存活,存活时间取决于许多因素,如表面类型、温度、相对湿度和病毒株类型。目前,COVID-19既没有治愈方法,也没有疫苗,这就是疾病传播如此可怕的原因。表面活性剂消毒成为阻止新冠病毒传播的原始措施。我们提出,基于生物表面活性剂的治疗方法及其对COVID-19的作用,通过使用基于生物表面活性剂的洗手液、漱口水或漱口水、鼻液和滴眼液,可以通过破坏病毒刺突糖蛋白(聚合物)来对抗SARS-CoV-2,这是由于它的两亲性和生物表面活性剂形成的胶束,冠状病毒被包裹在胶束内,因此从表面被冲走。这一假说揭示了生物表面活性剂对冠状病毒和SARS-CoV-2引起的急性呼吸窘迫综合征(ARDS)的作用。生物表面活性剂可通过口服途径以气溶胶形式给药,直接到达肺部感染部位,从而溶解被包膜的病毒衣壳,并增加肺泡表面积。两亲性天然生物表面活性剂通过在冠状病毒分子的疏水性刺突蛋白周围形成胶束,使S1和S2亚基不能附着在肺膜上,破坏冠状病毒膜,从而使刺突蛋白与膜分离。给肺部注射抗COVID-19的生物表面活性剂也会降低表面张力,从而降低塌陷压力。因此,肺泡表面积的增加使肺的正常功能成为可能。这项精心设计的相关动物模型研究是在生物水平上验证假设的关键一步,将证明对人体数据的验证至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信